CV Sciences, Inc. has confirmed the release of its financial results for the first quarter ending March 31, 2026, set for May 14, 2026, after the close of the stock market. This announcement is an important indicator for investors monitoring the company's financial health and performance in the consumer wellness sector.
Following the financial results announcement, CV Sciences will conduct a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on the same day. Participants are encouraged to join the call 15 minutes in advance due to anticipated high demand.
For those unable to attend, a webcast of the call will be available through the Investor Relations section of the CV Sciences website and will be stored for approximately 30 days for future viewing.
CV Sciences, Inc., traded under OTCQB:CVSI, is recognized as a key player in the wellness market, specializing in hemp extracts and other scientifically validated natural products. The company’s +PlusCBD™ line is noted as the best-selling hemp extract brand in the natural products industry, and its commitment to safety is underscored by the achievement of Generally Recognized as Safe (GRAS) status.
Moreover, CV Sciences offers a variety of non-cannabinoid supplements under the +PlusHLTH™ brand and plant-based food products via its Cultured Foods™ brand, catering to consumers seeking vegan and gluten-free options.
CV Sciences, Inc. is set to announce its first quarter results on May 14, 2026, after market close, which is a key moment for assessing its financial performance.
Investors can participate in the Q1 results conference call by dialing (877) 407-0784 for U.S. callers or (201) 689-8560 for international callers. It’s advisable to call in at least 15 minutes early due to expected high demand.
The webcast will be available on the Investor Relations section of CV Sciences’ website, offering investors an accessible way to follow the call and key updates.
CV Sciences, Inc. focuses on a range of consumer wellness products, notably its +PlusCBD™ line, which leads the market, underpinned by strong science-backed evidence.
+PlusCBD™ is the top-selling hemp-extract brand in the natural products market, reflecting the efficacy and popularity of its offerings among consumers.
The GRAS status attained by CV Sciences for its +PlusCBD™ product signifies a commitment to safety and scientific validation, enhancing trust and market position among consumers.
Through its Cultured Foods™ brand, CV Sciences provides a variety of plant-based products, targeting the growing demand for vegan and gluten-free options, which positions it well in a diverse dietary landscape.
CV Sciences’ products are distributed across various channels in the U.S. and Europe, indicating strategic market penetration that aligns with consumer trends in health and wellness.